Bristol-Myers Squibb Company

BMY · NYSE · Healthcare / Drug Manufacturers - General

63.43USD+1.11 (+1.78%)

Price History

Full chart

Market Stats

Previous Close62.32

Open62.56

Day Range61.81 – 63.79

52-Week Range43.34 – 67.94

Volume9.27M

Market Cap127.02B

P/E (TTM)13.78

Forward P/E9.39

EPS4.51

Dividend Yield4.06%

Beta0.19

50-Day Avg62.35

200-Day Avg60.14

About

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. The company offers products for oncology, hematology, immunology, cardiovascular, and neuroscience indications. Its products include Opdivo for anti-cancer indications; Opdivo Qvantig, a subcutaneous PD-1 inhibitor for solid tumors; Orencia for active rheumatoid arthritis and psoriatic arthritis; Yervoy for the treatment of unresectable or metastatic melanoma; Reblozyl to treat anemia; Breyanzi for the treatment of relapsed or refractory large B-cell lymphoma; Opdualag to treat unresectable or metastatic melanoma; and Camzyos for the treatment of symptomatic obstructive HCM. The company also offers Zeposia to treat relapsing forms of multiple sclerosis; Abecma for the treatment of patients with relapsed or refractory multiple myeloma; Sotyktu to treat moderate-to-severe plaque psoriasis; Krazati for the treatment of KRASG12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC); and Cobenfy to treat schizophrenia. In addition, it offers Eliquis for the reduction of risk of stroke/systemic embolism and for the treatment of DVT/PE; Revlimid, an oral immunomodulatory drug for multiple myeloma; Pomalyst/Imnovid for multiple myeloma; Sprycel for Philadelphia chromosome-positive chronic myeloid leukemia; and Abraxane to treat breast cancer. Further, the company provides Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC, as well as NSCLC and pancreatic cancer. It sells its products to wholesalers, distributors, specialty pharmacies, retailers, hospitals, clinics, and government agencies. The company has a strategic collaboration with Arcus Biosciences, Inc. to develop a treatment regimen that delivers tumor control in kidney cancer. The company was formerly known as Bristol-Myers Company. The company was founded in 1887 and is headquartered in Princeton, New Jersey.

Company Details

SectorHealthcare
IndustryDrug Manufacturers - General
CEODr. Christopher S. Boerner Ph.D.
Employees32.50K
HeadquartersRoute 206 & Province Line Road, Princeton, NJ, United States, 08543, USA
Websitehttps://www.bms.com

Leadership

Dr. Christopher S. Boerner Ph.D.CEO & Chairman · b. 1971
Mr. David V. ElkinsExecutive VP & CFO · b. 1968
Mr. Greg MeyersExecutive VP and Chief Digital & Technology Officer · b. 1973
Mr. Adam LenkowskyExecutive VP & Chief Commercialization Officer · b. 1972
Mr. Cristian Massacesi M.D.Executive VP, Chief Medical Officer & Head of Development · b. 1969
Ms. Karin ShanahanExecutive VP, Chief Supply Chain & Operations Officer · b. 1965
Mr. Charles E. TrianoSVP & Head of Investor Relations
Ms. Cari GallmanExecutive VP, General Counsel & Chief Policy Officer · b. 1980
Ms. Ahn Amanda PooleExecutive VP & Chief People Officer · b. 1975
Dr. Joseph J. Eiden Jr.Head of Medical Affairs · b. 1949

Financials

Income Statement

Currency: USD	1987-12-31	1988-12-31	1989-12-31	1990-12-31	1991-12-31	1992-12-31	1993-12-31	1994-12-31	1995-12-31	1996-12-31	1997-12-31	1998-12-31	1999-12-31	2000-12-31	2001-12-31	2002-12-31	2003-12-31	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31

Currency: USD	1987-12-31	1988-12-31	1989-12-31	1990-12-31	1991-12-31	1992-12-31	1993-12-31	1994-12-31	1995-12-31	1996-12-31	1997-12-31	1998-12-31	1999-12-31	2000-12-31	2001-12-31	2002-12-31	2003-12-31	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	7.56B	8.56B	9.19B	10.30B	11.16B	11.16B	11.41B	11.98B	13.77B	15.06B	16.70B	18.28B	20.22B	18.22B	19.42B	18.12B	20.89B	19.38B	19.21B	17.91B	19.35B	20.60B	18.81B	19.48B	21.24B	17.62B	16.39B	15.88B	16.56B	19.43B	20.78B	22.56B	26.14B	42.52B	46.38B	46.16B	45.01B	48.30B	48.20B
Growth (%)	-	+13.23%	+7.37%	+12.09%	+8.34%	-0.03%	+2.30%	+5.00%	+14.88%	+9.43%	+10.86%	+9.48%	+10.60%	-9.92%	+6.63%	-6.71%	+15.32%	-7.25%	-0.89%	-6.73%	+8.00%	+6.46%	-8.69%	+3.59%	+9.03%	-17.05%	-7.01%	-3.09%	+4.29%	+17.31%	+6.94%	+8.59%	+15.89%	+62.62%	+9.09%	-0.49%	-2.50%	+7.32%	-0.22%
Cost of Revenue	2.14B	2.30B	2.46B	2.63B	2.68B	2.56B	2.72B	2.79B	3.19B	3.45B	3.87B	3.27B	3.86B	4.76B	5.58B	6.53B	5.41B	5.99B	5.74B	5.74B	6.22B	5.32B	5.14B	5.28B	5.60B	4.61B	4.62B	3.93B	3.91B	4.97B	6.01B	6.47B	8.08B	11.77B	9.94B	10.14B	10.69B	13.97B	13.94B
Gross Profit	5.42B	6.26B	6.73B	7.67B	8.47B	8.59B	8.69B	9.19B	10.58B	11.62B	12.83B	11.79B	13.01B	13.46B	13.85B	11.57B	13.25B	13.39B	12.87B	11.52B	13.13B	12.40B	13.67B	14.21B	15.65B	13.01B	11.77B	11.95B	12.65B	14.46B	14.76B	16.09B	18.07B	30.75B	36.45B	36.02B	34.31B	34.33B	34.26B
Gross Margin	71.67%	73.14%	73.23%	74.47%	75.95%	77.03%	76.16%	76.69%	76.84%	77.13%	76.81%	64.48%	64.36%	73.87%	71.30%	63.88%	63.40%	69.10%	67.00%	64.29%	67.86%	60.20%	72.67%	72.92%	73.65%	73.84%	71.81%	75.24%	76.39%	74.42%	71.05%	71.34%	69.10%	72.31%	78.57%	78.04%	76.24%	71.08%	71.08%
Operating Expense	3.95B	4.49B	5.65B	5.28B	5.71B	6.63B	6.29B	5.97B	6.96B	7.67B	8.39B	7.33B	7.78B	7.47B	7.59B	7.47B	8.31B	8.93B	9.13B	9.13B	9.60B	7.38B	8.23B	8.26B	9.01B	9.08B	8.84B	10.23B	10.92B	9.99B	11.32B	10.98B	12.15B	28.57B	27.91B	26.92B	26.12B	28.45B	20.54B
Operating Income	1.47B	1.77B	1.08B	2.39B	2.77B	1.96B	2.40B	3.22B	3.62B	3.95B	4.44B	4.46B	5.24B	5.99B	6.25B	4.10B	4.93B	4.46B	3.74B	2.39B	3.53B	5.02B	5.44B	5.95B	6.64B	3.93B	2.93B	1.71B	1.73B	4.47B	3.45B	5.11B	5.91B	2.18B	8.54B	9.10B	8.20B	5.89B	13.72B
Operating Margin	19.41%	20.68%	11.79%	23.19%	24.79%	17.57%	21.05%	26.88%	26.26%	26.24%	26.57%	24.37%	25.91%	32.86%	32.19%	22.63%	23.61%	23.03%	19.46%	13.32%	18.23%	24.39%	28.92%	30.54%	31.24%	22.31%	17.89%	10.79%	10.45%	22.99%	16.59%	22.67%	22.62%	5.12%	18.40%	19.72%	18.21%	12.19%	28.48%
EBITDA	1.63B	1.96B	1.28B	2.63B	3.01B	2.25B	2.71B	3.55B	4.06B	4.47B	5.03B	5.08B	5.92B	6.73B	10.25B	4.84B	5.72B	5.37B	4.67B	3.31B	4.42B	5.90B	6.49B	6.82B	7.75B	3.20B	3.85B	3.05B	2.64B	6.46B	6.12B	6.79B	7.38B	4.93B	20.12B	19.22B	19.37B	3.17B	15.23B
EBITDA Margin	21.54%	22.84%	13.92%	25.56%	26.99%	20.21%	23.75%	29.61%	29.51%	29.68%	30.11%	27.79%	29.26%	36.96%	52.78%	26.69%	27.39%	27.72%	24.29%	18.49%	22.84%	28.65%	34.52%	35.02%	36.50%	18.18%	23.52%	19.21%	15.92%	33.27%	29.44%	30.09%	28.22%	11.59%	43.37%	41.64%	43.03%	6.56%	31.60%
Net Income	1.07B	1.25B	747.00M	1.75B	2.06B	1.96B	1.96B	1.84B	1.81B	2.85B	3.21B	3.14B	4.17B	4.71B	5.25B	2.14B	3.11B	2.39B	3.00B	1.58B	2.17B	5.25B	10.61B	3.10B	3.71B	1.96B	2.56B	2.00B	1.56B	4.46B	1.01B	4.92B	3.44B	-9.02B	6.99B	6.33B	8.03B	-8.95B	7.05B
Net Income Margin	14.13%	14.65%	8.13%	16.97%	18.42%	17.59%	17.16%	15.37%	13.16%	18.92%	19.19%	17.18%	20.61%	25.86%	27.00%	11.79%	14.87%	12.32%	15.62%	8.85%	11.19%	25.47%	56.42%	15.92%	17.46%	11.12%	15.64%	12.62%	9.45%	22.94%	4.85%	21.81%	13.15%	-21.20%	15.08%	13.71%	17.83%	-18.53%	14.64%
R&D	-	-	-	-	-	-	-	1.11B	1.20B	1.28B	1.39B	1.51B	1.76B	1.94B	2.26B	2.21B	2.28B	2.50B	2.68B	2.99B	3.28B	3.51B	3.65B	3.57B	3.84B	3.90B	3.73B	4.53B	5.92B	5.01B	6.47B	6.33B	6.15B	11.14B	10.20B	9.51B	9.30B	11.16B	9.95B
R&D as % of Total Revenue	-	-	-	-	-	-	-	9.25%	8.71%	8.47%	8.29%	8.24%	8.70%	10.64%	11.63%	12.18%	10.91%	12.90%	13.94%	16.70%	16.96%	17.05%	19.39%	18.30%	18.07%	22.16%	22.77%	28.55%	35.75%	25.80%	31.13%	28.07%	23.52%	26.21%	21.98%	20.60%	20.66%	23.10%	20.65%
Interest Expense	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	410.00M	0	0	0	0	0	310.00M	184.00M	273.00M	145.00M	182.00M	199.00M	203.00M	184.00M	167.00M	196.00M	183.00M	656.00M	1.42B	1.33B	1.23B	1.17B	1.95B	1.89B
Interest Expense % of Total Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	2.26%	0.00%	0.00%	0.00%	0.00%	0.00%	1.51%	0.98%	1.40%	0.68%	1.03%	1.21%	1.28%	1.11%	0.86%	0.94%	0.81%	2.51%	3.34%	2.88%	2.67%	2.59%	4.03%	3.92%

Balance Sheet

Currency: USD	1987-12-31	1988-12-31	1989-12-31	1990-12-31	1991-12-31	1992-12-31	1993-12-31	1994-12-31	1995-12-31	1996-12-31	1997-12-31	1998-12-31	1999-12-31	2000-12-31	2001-12-31	2002-12-31	2003-12-31	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31

Currency: USD	1987-12-31	1988-12-31	1989-12-31	1990-12-31	1991-12-31	1992-12-31	1993-12-31	1994-12-31	1995-12-31	1996-12-31	1997-12-31	1998-12-31	1999-12-31	2000-12-31	2001-12-31	2002-12-31	2003-12-31	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	7.51B	8.27B	8.50B	9.21B	9.42B	10.80B	12.10B	12.91B	13.93B	14.69B	14.98B	16.27B	17.11B	17.58B	27.06B	25.02B	27.45B	30.43B	28.14B	25.57B	26.17B	29.49B	31.01B	31.08B	32.97B	35.90B	38.59B	33.75B	31.75B	33.71B	33.55B	34.99B	129.94B	118.48B	109.31B	96.82B	95.16B	92.60B	90.04B
Total Liabilities	2.76B	3.33B	3.41B	3.80B	3.62B	4.78B	6.16B	7.21B	8.11B	8.12B	7.76B	8.70B	8.47B	8.40B	16.32B	16.27B	17.66B	20.23B	16.93B	15.58B	15.61B	17.28B	16.22B	15.44B	17.10B	22.26B	23.36B	18.77B	17.32B	17.36B	21.70B	20.86B	78.25B	80.60B	73.31B	65.70B	65.67B	76.22B	71.53B
Total Equity	4.75B	4.95B	5.08B	5.42B	5.79B	6.02B	5.94B	5.70B	5.82B	6.57B	7.22B	7.58B	8.64B	9.18B	10.74B	8.76B	9.79B	10.20B	11.21B	9.99B	10.56B	12.24B	14.84B	15.71B	15.96B	13.62B	15.15B	14.85B	14.27B	16.18B	11.74B	14.03B	51.60B	37.82B	35.95B	31.06B	29.43B	16.34B	18.47B
Cash	2.35B	2.51B	510.00M	596.00M	1.44B	2.14B	2.42B	1.64B	1.65B	1.68B	1.46B	2.24B	2.72B	3.18B	5.50B	2.37B	2.55B	3.68B	3.05B	2.02B	1.80B	7.98B	7.68B	5.03B	5.78B	1.66B	3.59B	5.57B	2.38B	4.24B	5.42B	6.91B	12.35B	14.55B	13.98B	9.12B	11.46B	10.35B	10.21B
Total Debt	694.00M	963.00M	518.00M	628.00M	688.00M	551.00M	765.00M	1.37B	1.21B	1.48B	1.82B	1.85B	1.77B	1.50B	6.41B	7.64B	8.75B	10.35B	8.60B	7.43B	6.27B	6.74B	6.36B	5.45B	5.49B	7.39B	8.34B	7.83B	6.69B	6.71B	7.96B	7.35B	47.54B	51.67B	45.60B	40.72B	41.46B	51.20B	47.14B
Net Debt	-1.65B	-1.55B	8.00M	32.00M	-747.00M	-1.59B	-1.66B	-273.00M	-435.00M	-202.00M	366.00M	-398.00M	-946.00M	-1.68B	911.00M	5.27B	6.21B	6.67B	5.54B	5.42B	4.47B	-1.24B	-1.32B	412.00M	-285.00M	5.74B	4.75B	2.26B	4.30B	2.47B	2.54B	438.00M	35.19B	37.13B	31.62B	31.59B	30.00B	40.85B	36.93B

Cash Flow

Currency: USD	1989-12-31	1990-12-31	1991-12-31	1992-12-31	1993-12-31	1994-12-31	1995-12-31	1996-12-31	1997-12-31	1998-12-31	1999-12-31	2000-12-31	2001-12-31	2002-12-31	2003-12-31	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31

Currency: USD	1989-12-31	1990-12-31	1991-12-31	1992-12-31	1993-12-31	1994-12-31	1995-12-31	1996-12-31	1997-12-31	1998-12-31	1999-12-31	2000-12-31	2001-12-31	2002-12-31	2003-12-31	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	1.19B	1.75B	1.83B	2.03B	2.58B	2.30B	2.50B	2.64B	2.48B	3.78B	4.22B	4.65B	5.40B	945.00M	3.51B	3.18B	1.84B	2.08B	3.15B	3.71B	4.07B	4.49B	4.84B	6.94B	3.54B	3.15B	2.10B	3.06B	5.28B	7.07B	8.07B	14.05B	16.21B	13.07B	13.86B	15.19B	14.16B
Investing Cash Flow	-1.63B	-164.00M	571.00M	430.00M	-597.00M	-1.42B	-631.00M	-717.00M	-532.00M	-346.00M	-759.00M	16.00M	-	-2.03B	-2.42B	-1.62B	1.19B	206.00M	-202.00M	5.08B	-4.38B	-3.81B	-1.44B	-6.73B	-572.00M	1.22B	-1.57B	1.48B	-66.00M	-2.00B	-9.77B	-10.86B	-538.00M	-1.06B	-2.29B	-21.35B	-4.13B
Financing Cash Flow	-1.01B	-1.49B	-1.58B	-1.75B	-1.70B	-1.64B	-1.86B	-1.89B	-2.15B	-2.64B	-2.95B	-4.16B	1.77B	-1.12B	-1.03B	-463.00M	-3.64B	-3.35B	-3.21B	-2.58B	-17.00M	-3.34B	-2.66B	-4.33B	-1.07B	-2.44B	-3.62B	-2.65B	-4.08B	-3.54B	7.62B	-1.15B	-16.22B	-16.96B	-9.42B	5.13B	-10.35B
Capital Expenditure	555.00M	513.00M	628.00M	647.00M	570.00M	573.00M	513.00M	601.00M	767.00M	788.00M	709.00M	589.00M	1.02B	1.18B	990.00M	809.00M	768.00M	793.00M	843.00M	941.00M	730.00M	424.00M	367.00M	548.00M	537.00M	526.00M	820.00M	1.22B	1.05B	951.00M	836.00M	753.00M	973.00M	1.12B	1.21B	1.25B	1.31B
Free Cash Flow	635.00M	1.24B	1.21B	1.38B	2.01B	1.73B	1.99B	2.04B	1.71B	2.99B	3.52B	4.06B	4.38B	-237.00M	2.52B	2.37B	1.07B	1.29B	2.31B	2.77B	3.33B	4.07B	4.47B	6.39B	3.01B	2.62B	1.28B	1.84B	4.22B	6.12B	7.23B	13.30B	15.23B	11.95B	12.65B	13.94B	12.85B
Dividends Paid	722.00M	1.12B	1.25B	1.43B	1.49B	1.49B	1.50B	1.51B	1.51B	1.55B	1.71B	1.93B	2.14B	2.17B	2.17B	2.17B	2.19B	2.20B	2.21B	2.46B	2.48B	2.20B	2.25B	2.29B	2.31B	2.40B	2.48B	2.55B	2.58B	2.61B	2.68B	4.08B	4.40B	4.63B	4.74B	4.86B	5.04B
FCF to OCF	53.36%	70.72%	65.78%	68.10%	77.91%	75.10%	79.47%	77.24%	69.02%	79.16%	83.21%	87.34%	81.06%	-25.08%	71.81%	74.53%	58.17%	61.93%	73.26%	74.62%	82.04%	90.56%	92.42%	92.10%	84.85%	83.29%	61.05%	60.27%	80.00%	86.54%	89.64%	94.64%	94.00%	91.44%	91.28%	91.78%	90.74%
Dividend Paid to FCF	113.70%	90.07%	103.48%	103.40%	73.88%	85.94%	75.28%	73.87%	88.65%	51.80%	48.56%	47.50%	48.80%	-914.77%	86.00%	91.85%	204.68%	170.47%	95.80%	88.97%	74.45%	54.14%	50.39%	35.76%	76.76%	91.46%	192.76%	138.20%	61.07%	42.73%	37.05%	30.64%	28.86%	38.78%	37.50%	34.88%	39.28%

Earnings

Report Date	Apr 23, 1996	Jul 22, 1996	Oct 22, 1996	Jan 22, 1997	Apr 22, 1997	Jul 22, 1997	Oct 21, 1997	Jan 22, 1998	Apr 21, 1998	Jul 21, 1998	Oct 20, 1998	Jan 20, 1999	Apr 21, 1999	Jul 21, 1999	Oct 19, 1999	Jan 24, 2000	Apr 20, 2000	Jul 20, 2000	Oct 19, 2000	Jan 24, 2001	Apr 25, 2001	Jul 25, 2001	Oct 23, 2001	Jan 24, 2002	Apr 25, 2002	Jul 23, 2002	Oct 24, 2002	Mar 10, 2003	Apr 29, 2003	Jul 24, 2003	Oct 23, 2003	Jan 29, 2004	Apr 28, 2004	Jul 29, 2004	Oct 29, 2004	Jan 27, 2005	Apr 28, 2005	Jul 28, 2005	Oct 28, 2005	Jan 25, 2006	Apr 27, 2006	Jul 27, 2006	Oct 26, 2006	Jan 25, 2007	Apr 26, 2007	Jul 26, 2007	Oct 25, 2007	Jan 31, 2008	Apr 24, 2008	Jul 24, 2008	Oct 23, 2008	Jan 27, 2009	Apr 28, 2009	Jul 23, 2009	Oct 22, 2009	Jan 28, 2010	Apr 29, 2010	Jul 22, 2010	Oct 26, 2010	Jan 27, 2011	Apr 28, 2011	Jul 28, 2011	Oct 27, 2011	Jan 26, 2012	Apr 26, 2012	Jul 25, 2012	Oct 24, 2012	Jan 24, 2013	Apr 25, 2013	Jul 25, 2013	Oct 23, 2013	Jan 24, 2014	Apr 29, 2014	Jul 24, 2014	Oct 24, 2014	Jan 27, 2015	Apr 28, 2015	Jul 23, 2015	Oct 27, 2015	Jan 28, 2016	Apr 28, 2016	Jul 28, 2016	Oct 27, 2016	Jan 26, 2017	Apr 27, 2017	Jul 27, 2017	Oct 26, 2017	Feb 5, 2018	Apr 26, 2018	Jul 26, 2018	Oct 25, 2018	Jan 24, 2019	Apr 25, 2019	Jul 25, 2019	Oct 31, 2019	Feb 6, 2020	May 7, 2020	Aug 6, 2020	Nov 5, 2020	Feb 4, 2021	Apr 29, 2021	Jul 28, 2021	Oct 27, 2021	Feb 4, 2022	Apr 29, 2022	Jul 27, 2022	Oct 25, 2022	Feb 2, 2023	Apr 27, 2023	Jul 27, 2023	Oct 26, 2023	Feb 2, 2024	Apr 25, 2024	Jul 26, 2024	Oct 31, 2024	Feb 6, 2025	Apr 24, 2025	Jul 31, 2025	Oct 30, 2025	Feb 5, 2026	Apr 30, 2026	Jul 30, 2026	Oct 29, 2026
EPS Estimate	0.33	0.31	0.35	0.34	0.38	0.35	0.40	0.38	0.43	0.39	0.45	0.43	0.49	0.45	0.51	0.49	0.57	0.51	0.58	0.55	0.61	0.53	0.63	0.59	0.43	0.27	0.27	0.27	0.38	0.38	0.41	0.40	0.39	0.39	0.39	0.33	0.34	0.36	0.33	0.28	0.32	0.32	0.20	0.16	0.23	0.36	0.36	0.34	0.41	0.40	0.42	0.41	0.47	0.47	0.51	0.42	0.51	0.53	0.53	0.47	0.53	0.55	0.58	0.55	0.64	0.48	0.42	0.43	0.42	0.44	0.44	0.43	0.43	0.44	0.42	0.41	0.51	0.36	0.35	0.28	0.65	0.66	0.65	0.66	0.74	0.73	0.77	0.67	0.85	0.87	0.91	0.85	1.08	1.06	1.07	1.16	1.45	1.48	1.49	1.42	1.81	1.90	1.92	1.80	1.90	1.80	1.83	1.73	1.97	1.99	1.77	1.43	-4.14	1.63	1.50	1.47	1.50	1.10	1.52	1.20	1.42	1.59	1.21
EPS Actual	0.34	0.31	0.36	0.34	0.38	0.35	0.41	0.38	0.43	0.40	0.45	0.43	0.50	0.45	0.51	0.49	0.58	0.51	0.59	0.56	0.63	0.56	0.63	0.59	0.45	0.23	0.26	0.31	0.39	0.44	0.47	0.37	0.41	0.46	0.44	0.39	0.41	0.47	0.31	0.31	0.32	0.35	0.22	0.19	0.38	0.37	0.38	0.35	0.42	0.43	0.46	0.46	0.48	0.56	0.52	0.47	0.56	0.54	0.59	0.47	0.58	0.56	0.61	0.53	0.64	0.48	0.41	0.47	0.41	0.44	0.46	0.51	0.46	0.48	0.45	0.46	0.71	0.53	0.39	0.38	0.74	0.69	0.77	0.63	0.84	0.74	0.75	0.68	0.94	1.01	1.09	0.94	1.10	1.18	1.17	1.22	1.72	1.63	1.63	1.46	1.74	1.93	2.00	1.83	1.96	1.93	1.99	1.82	2.05	1.75	2.00	1.59	-4.40	2.07	1.80	1.67	1.80	1.46	1.63	1.26	1.58	2.04	1.35
Surprise	3.03%	0.00%	2.86%	0.00%	0.00%	0.00%	2.50%	0.00%	0.00%	2.56%	0.00%	0.00%	2.04%	0.00%	0.00%	0.00%	1.75%	0.00%	1.72%	1.82%	3.28%	5.66%	0.00%	0.00%	4.65%	-14.81%	-3.70%	14.81%	2.63%	15.79%	14.63%	-7.50%	5.13%	17.95%	12.82%	18.18%	20.59%	30.56%	-6.06%	10.71%	0.00%	9.38%	10.00%	18.75%	65.22%	2.78%	5.56%	2.94%	2.44%	7.50%	9.52%	12.20%	2.13%	19.15%	1.96%	11.90%	9.80%	1.89%	11.32%	0.00%	9.43%	1.82%	5.17%	-3.64%	0.00%	0.00%	-2.38%	9.30%	-2.38%	0.00%	4.55%	18.60%	6.98%	9.09%	7.14%	12.20%	39.22%	47.22%	11.43%	35.71%	13.85%	4.55%	18.46%	-4.55%	13.51%	1.37%	-2.60%	1.49%	10.59%	16.09%	19.78%	10.59%	1.85%	11.32%	9.35%	5.17%	18.62%	10.14%	9.40%	2.82%	-3.87%	1.58%	4.17%	1.67%	3.16%	7.22%	8.74%	5.20%	4.06%	-12.06%	12.99%	11.19%	-6.28%	26.99%	20.00%	13.61%	20.00%	32.73%	7.24%	5.00%	11.27%	28.30%	11.57%
Timing	-	-	-	-	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	-	-	-	-	-	-	-	-	-	-	-	-	-	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	-	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	After-hours	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market

Key Statistics & Ratios

Market Cap127.02B

Enterprise Value159.25B

Trailing P/E13.78

Forward P/E9.39

PEG Ratio17.07

Price / Sales2.54

Price / Book5.43

EPS4.51

Book Value11.45

Revenue (TTM)50.03B

Gross Profit (TTM)35.28B

EBITDA18.24B

Profit Margin18.47%

Operating Margin33.79%

Return on Equity44.01%

Return on Assets10.90%

Shares Outstanding2.04B

Shares Float2.04B

Beta0.19

Dividend Yield4.06%

Dividend Rate2.52

Payout Ratio40.45%

Analyst Ratings

Buy

Based on 28 analystsTarget 65.25

Strong Buy
6
Buy
4
Hold
17
Strong Sell
1

Ownership Breakdown

Institutions: 84.44%
Insiders: 0.10%
Retail / Other: 15.46%

Top Institutional Holders

BlackRock Inc
180.38M8.82%
Vanguard Capital Management, LLC
133.34M6.52%
State Street Corp
102.41M5.01%
JPMorgan Chase & Co
71.71M3.51%
Charles Schwab Investment Management Inc
67.60M3.31%
Geode Capital Management, LLC
56.44M2.76%
Vanguard Portfolio Management, LLC
46.87M2.29%
NORGES BANK
36.87M1.80%
Bank of America Corp
34.05M1.67%
T. Rowe Price Associates, Inc.
31.71M1.55%
Morgan Stanley - Brokerage Accounts
29.01M1.42%
AQR Capital Management LLC
27.36M1.34%
Ameriprise Financial Inc
26.67M1.30%
PRIMECAP Management Company
24.92M1.22%

Top Fund Holders

Vanguard MStar Total Stk Mkt Idx Invest
64.85M3.17%
Schwab US Dividend Equity ETF™
58.11M2.84%
Vanguard 500 Index Investor
53.65M2.62%
iShares Core S&P 500 ETF
27.18M1.33%
Fidelity 500 Index
26.51M1.30%
State Street® SPDR® S&P 500® ETF
24.98M1.22%

Dividends

20263×

0.63Jul 2, 20260.63Apr 2, 20260.63Jan 2, 2026

20254×

0.62Oct 3, 20250.62Jul 3, 20250.62Apr 4, 20250.62Jan 3, 2025

20244×

0.60Oct 4, 20240.60Jul 5, 20240.60Apr 4, 20240.60Jan 4, 2024

20234×

0.57Oct 5, 20230.57Jul 6, 20230.57Apr 6, 20230.57Jan 5, 2023

20224×

0.54Oct 6, 20220.54Jun 30, 20220.54Mar 31, 20220.54Jan 6, 2022

20213×

0.49Sep 30, 20210.49Jul 1, 20210.49Mar 31, 2021

20202×

0.49Dec 31, 20200.45Oct 1, 2020

Stock Splits

Aug 7, 20011000000:951777
Mar 1, 19992:1
Mar 3, 19972:1
Jun 10, 19872:1
May 27, 19832:1
May 31, 19772:1